CRISIL Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 21, 2025, 2:07 pm

Market Cap	34,225 Cr.
Current Price	4,680
High / Low	6,955/3,880
Stock P/E	51.8
Book Value	351
Dividend Yield	1.23 %
ROCE	35.6 %
ROE	27.8 %
Face Value	1.00
PEG Ratio	3.74

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for CRISIL Ltd

Competitors of CRISIL Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
IMEC Services Ltd	11.2 Cr.	59.0	93.4/6.65	4.05	13.4	0.00 %	2.47 %	1.85 %	10.0
Focus Business Solution Ltd	41.5 Cr.	90.0	105/59.6	84.6	14.7	0.11 %	16.1 %	13.5 %	10.0
EKI Energy Services Ltd	272 Cr.	98.5	407/82.4		153	2.03 %	24.0 %	26.2 %	10.0
CMS Info Systems Ltd	7,665 Cr.	470	616/376	21.5	124	1.21 %	27.5 %	20.5 %	10.0
Ashram Online.Com Ltd	6.60 Cr.	5.50	8.02/4.11	132	10.6	0.00 %	0.24 %	0.08 %	10.0
Industry Average	12,388.21 Cr	868.13		42.17	262.99	0.59%	14.95%	13.13%	9.05

All Competitor Stocks of CRISIL Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	706	595	669	683	822	715	771	736	918	738	797	812	913
Expenses	514	419	499	531	606	511	567	544	649	546	591	588	626
Operating Profit	193	176	169	151	216	203	204	192	269	192	207	224	287
OPM %	27%	30%	25%	22%	26%	28%	26%	26%	29%	26%	26%	28%	31%
Other Income	59	20	35	65	18	17	18	36	36	21	18	21	30
Interest	2	2	2	2	1	1	1	1	1	1	1	1	2
Depreciation	25	25	26	26	26	26	26	26	25	17	16	16	21
Profit before tax	225	169	177	189	207	194	195	200	279	195	208	229	294
Tax %	25%	28%	23%	22%	24%	25%	23%	24%	25%	30%	28%	25%	24%
Net Profit	169	122	137	148	158	146	151	152	210	138	150	172	225
EPS in Rs	23.14	16.67	18.75	20.24	21.63	19.94	20.60	20.79	28.74	18.84	20.53	23.46	30.72

Last Updated: March 3, 2025, 4:54 pm

Below is a detailed analysis of the quarterly data for CRISIL Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 913.00 Cr.. The value appears strong and on an upward trend. It has increased from 812.00 Cr. (Sep 2024) to 913.00 Cr., marking an increase of 101.00 Cr..
For Expenses, as of Dec 2024, the value is 626.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 588.00 Cr. (Sep 2024) to 626.00 Cr., marking an increase of 38.00 Cr..
For Operating Profit, as of Dec 2024, the value is 287.00 Cr.. The value appears strong and on an upward trend. It has increased from 224.00 Cr. (Sep 2024) to 287.00 Cr., marking an increase of 63.00 Cr..
For OPM %, as of Dec 2024, the value is 31.00%. The value appears strong and on an upward trend. It has increased from 28.00% (Sep 2024) to 31.00%, marking an increase of 3.00%.
For Other Income, as of Dec 2024, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Sep 2024) to 30.00 Cr., marking an increase of 9.00 Cr..
For Interest, as of Dec 2024, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
For Depreciation, as of Dec 2024, the value is 21.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Sep 2024) to 21.00 Cr., marking an increase of 5.00 Cr..
For Profit before tax, as of Dec 2024, the value is 294.00 Cr.. The value appears strong and on an upward trend. It has increased from 229.00 Cr. (Sep 2024) to 294.00 Cr., marking an increase of 65.00 Cr..
For Tax %, as of Dec 2024, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Sep 2024) to 24.00%, marking a decrease of 1.00%.
For Net Profit, as of Dec 2024, the value is 225.00 Cr.. The value appears strong and on an upward trend. It has increased from 172.00 Cr. (Sep 2024) to 225.00 Cr., marking an increase of 53.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 30.72. The value appears strong and on an upward trend. It has increased from 23.46 (Sep 2024) to 30.72, marking an increase of 7.26.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:32 pm

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales	1,111	1,253	1,380	1,548	1,658	1,748	1,732	1,982	2,301	2,769	3,140	3,260
Expenses	750	865	980	1,104	1,203	1,277	1,276	1,471	1,690	2,039	2,258	2,349
Operating Profit	361	389	400	443	455	471	456	511	611	730	882	911
OPM %	32%	31%	29%	29%	27%	27%	26%	26%	27%	26%	28%	28%
Other Income	103	24	43	50	25	73	73	83	123	122	94	90
Interest	0	0	0	0	0	2	0	14	9	6	4	4
Depreciation	38	36	37	55	47	43	37	121	106	103	104	70
Profit before tax	425	376	406	438	434	500	492	458	618	742	868	926
Tax %	30%	29%	30%	33%	30%	27%	30%	23%	25%	24%	24%	26%
Net Profit	298	268	285	294	304	363	344	355	466	564	658	684
EPS in Rs	42.16	37.62	40.04	41.26	42.46	50.35	47.57	48.87	63.92	77.25	90.06	93.54
Dividend Payout %	45%	53%	57%	65%	66%	60%	67%	68%	72%	62%	60%	28%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:	10%
5 Years:	13%
3 Years:	12%
TTM:	4%

Compounded Profit Growth
10 Years:	10%
5 Years:	14%
3 Years:	16%
TTM:	3%

Stock Price CAGR
10 Years:	10%
5 Years:	27%
3 Years:	12%
1 Year:	8%

Return on Equity
10 Years:	30%
5 Years:	30%
3 Years:	31%
Last Year:	28%

Last Updated: Unknown

Balance Sheet

Last Updated: April 13, 2025, 3:51 pm

Month	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Equity Capital	7	7	7	7	7	7	7	7	7	7	7	7
Reserves	667	841	849	978	1,041	1,129	1,165	1,305	1,571	1,785	2,182	2,558
Borrowings	0	0	0	0	0	3	3	0	132	83	47	250
Other Liabilities	470	416	475	400	446	495	514	895	793	956	1,061	1,127
Total Liabilities	1,145	1,265	1,331	1,385	1,495	1,634	1,689	2,207	2,504	2,831	3,297	3,942
Fixed Assets	449	432	413	309	293	350	349	763	661	619	635	976
CWIP	0	0	3	4	13	7	12	14	5	14	31	55
Investments	244	375	383	465	525	477	453	476	645	683	1,056	1,454
Other Assets	451	458	532	607	663	800	875	955	1,193	1,515	1,576	1,457
Total Assets	1,145	1,265	1,331	1,385	1,495	1,634	1,689	2,207	2,504	2,831	3,297	3,942

Below is a detailed analysis of the balance sheet data for CRISIL Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Equity Capital, as of Dec 2024, the value is ₹7.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2023) which recorded 7.00 Cr..
For Reserves, as of Dec 2024, the value is ₹2,558.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,182.00 Cr. (Dec 2023) to ₹2,558.00 Cr., marking an increase of 376.00 Cr..
For Borrowings, as of Dec 2024, the value is ₹250.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 47.00 Cr. (Dec 2023) to ₹250.00 Cr., marking an increase of 203.00 Cr..
For Other Liabilities, as of Dec 2024, the value is ₹1,127.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,061.00 Cr. (Dec 2023) to ₹1,127.00 Cr., marking an increase of 66.00 Cr..
For Total Liabilities, as of Dec 2024, the value is ₹3,942.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,297.00 Cr. (Dec 2023) to ₹3,942.00 Cr., marking an increase of 645.00 Cr..
For Fixed Assets, as of Dec 2024, the value is ₹976.00 Cr.. The value appears strong and on an upward trend. It has increased from 635.00 Cr. (Dec 2023) to ₹976.00 Cr., marking an increase of 341.00 Cr..
For CWIP, as of Dec 2024, the value is ₹55.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Dec 2023) to ₹55.00 Cr., marking an increase of 24.00 Cr..
For Investments, as of Dec 2024, the value is ₹1,454.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,056.00 Cr. (Dec 2023) to ₹1,454.00 Cr., marking an increase of 398.00 Cr..
For Other Assets, as of Dec 2024, the value is ₹1,457.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,576.00 Cr. (Dec 2023) to ₹1,457.00 Cr., marking a decrease of 119.00 Cr..
For Total Assets, as of Dec 2024, the value is ₹3,942.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,297.00 Cr. (Dec 2023) to ₹3,942.00 Cr., marking an increase of 645.00 Cr..

Notably, the Reserves (2,558.00 Cr.) exceed the Borrowings (250.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

No data available for this post.

Free Cash Flow

Month	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Free Cash Flow	361.00	389.00	400.00	443.00	455.00	468.00	453.00	511.00	479.00	647.00	835.00	661.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023
Debtor Days	44	39	41	52	49	57	59	42	57	86	100	80
Inventory Days
Days Payable
Cash Conversion Cycle	44	39	41	52	49	57	59	42	57	86	100	80
Working Capital Days	-95	-86	-46	-39	-7	2	-8	-26	-35	-9	8	-5
ROCE %	66%	60%	48%	45%	45%	41%	45%	42%	37%	38%	41%	41%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	66.92%	66.88%	66.79%	66.74%	66.72%	66.70%	66.69%	66.67%	66.66%	66.65%	66.65%	66.64%
FIIs	6.59%	6.84%	6.65%	6.58%	6.69%	6.68%	6.90%	7.17%	7.25%	7.19%	7.20%	7.17%
DIIs	5.96%	6.38%	7.00%	7.50%	13.10%	13.03%	13.16%	13.18%	13.08%	12.92%	12.94%	12.49%
Public	20.53%	19.90%	19.56%	19.19%	13.50%	13.59%	13.27%	12.99%	13.01%	13.23%	13.21%	13.69%
No. of Shareholders	42,911	44,208	46,670	52,585	54,162	54,551	47,276	42,125	43,145	46,428	49,675	58,612

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
SBI Magnum Midcap Fund	1,395,281	3.39	607.83	1,395,281	2025-04-20 14:33:15	0%
Kotak Equity Opportunities Fund - Regular Plan	555,000	1.12	241.78	555,000	2025-04-19 20:02:05	0%
Quant Active Fund	402,300	1.79	175.26	402,300	2025-04-20 14:33:15	0%
HSBC Midcap Fund	375,147	1.58	163.43	375,147	2025-04-20 14:33:15	0%
Quant Mid Cap Fund	263,137	1.66	114.63	263,137	2025-04-20 14:33:15	0%
Aditya Birla Sun Life MNC Fund - Div	214,418	2.56	93.41	214,418	2025-04-20 14:33:15	0%
Aditya Birla Sun Life MNC Fund - Gr	214,418	2.56	93.41	214,418	2025-04-20 14:33:15	0%
PGIM India Midcap Opportunities Fund	173,973	0.75	75.79	173,973	2025-04-21 09:36:33	0%
UTI MNC Fund	136,975	2.1	59.67	136,975	2025-04-20 14:33:15	0%
Kotak ELSS Tax Saver Fund	115,000	0.89	50.1	115,000	2025-04-20 14:33:15	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
FaceValue	1.00	1.00	1.00	1.00	1.00
Basic EPS (Rs.)	90.08	77.31	64.03	48.93	47.61
Diluted EPS (Rs.)	90.07	77.31	63.96	48.93	47.55
Cash EPS (Rs.)	104.27	91.34	78.43	65.54	52.67
Book Value[Excl.RevalReserv]/Share (Rs.)	299.44	245.14	216.21	180.69	162.09
Book Value[Incl.RevalReserv]/Share (Rs.)	299.44	245.14	216.21	180.69	162.09
Revenue From Operations / Share (Rs.)	429.48	378.76	315.60	272.98	239.52
PBDIT / Share (Rs.)	133.40	116.57	94.31	81.79	73.12
PBIT / Share (Rs.)	119.20	102.44	79.77	65.11	68.02
PBT / Share (Rs.)	118.70	101.56	84.83	63.13	67.99
Net Profit / Share (Rs.)	90.07	77.21	63.90	48.86	47.57
NP After MI And SOA / Share (Rs.)	90.07	77.21	63.90	48.86	47.57
PBDIT Margin (%)	31.06	30.77	29.88	29.96	30.52
PBIT Margin (%)	27.75	27.04	25.27	23.85	28.40
PBT Margin (%)	27.63	26.81	26.88	23.12	28.38
Net Profit Margin (%)	20.97	20.38	20.24	17.89	19.86
NP After MI And SOA Margin (%)	20.97	20.38	20.24	17.89	19.86
Return on Networth / Equity (%)	30.08	31.49	29.55	27.04	29.34
Return on Capital Employeed (%)	37.75	39.67	34.16	31.14	41.15
Return On Assets (%)	19.86	19.93	18.60	16.07	20.36
Asset Turnover Ratio (%)	1.02	1.04	0.65	0.58	0.61
Current Ratio (X)	2.08	1.87	1.79	1.57	1.95
Quick Ratio (X)	2.08	1.87	1.79	1.57	1.95
Dividend Payout Ratio (NP) (%)	54.39	60.79	59.35	65.41	63.01
Dividend Payout Ratio (CP) (%)	46.98	51.39	48.35	48.76	56.91
Earning Retention Ratio (%)	45.61	39.21	40.65	34.59	36.99
Cash Earning Retention Ratio (%)	53.02	48.61	51.65	51.24	43.09
Interest Coverage Ratio (X)	266.43	133.14	76.99	41.26	2298.61
Interest Coverage Ratio (Post Tax) (X)	180.90	89.19	48.03	25.65	1496.43
Enterprise Value (Cr.)	31351.85	22093.95	20741.31	13681.21	13468.15
EV / Net Operating Revenue (X)	9.99	7.98	9.02	6.90	7.78
EV / EBITDA (X)	32.15	25.93	30.17	23.04	25.48
MarketCap / Net Operating Revenue (X)	10.10	8.10	9.14	7.04	7.98
Retention Ratios (%)	45.60	39.20	40.64	34.58	36.98
Price / BV (X)	14.49	12.51	13.35	10.64	11.79
Price / Net Operating Revenue (X)	10.10	8.10	9.14	7.04	7.98
EarningsYield	0.02	0.02	0.02	0.02	0.02

After reviewing the key financial ratios for CRISIL Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Dec 23, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Dec 22) which recorded 1.00.
For Basic EPS (Rs.), as of Dec 23, the value is 90.08. This value is within the healthy range. It has increased from 77.31 (Dec 22) to 90.08, marking an increase of 12.77.
For Diluted EPS (Rs.), as of Dec 23, the value is 90.07. This value is within the healthy range. It has increased from 77.31 (Dec 22) to 90.07, marking an increase of 12.76.
For Cash EPS (Rs.), as of Dec 23, the value is 104.27. This value is within the healthy range. It has increased from 91.34 (Dec 22) to 104.27, marking an increase of 12.93.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 299.44. It has increased from 245.14 (Dec 22) to 299.44, marking an increase of 54.30.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 299.44. It has increased from 245.14 (Dec 22) to 299.44, marking an increase of 54.30.
For Revenue From Operations / Share (Rs.), as of Dec 23, the value is 429.48. It has increased from 378.76 (Dec 22) to 429.48, marking an increase of 50.72.
For PBDIT / Share (Rs.), as of Dec 23, the value is 133.40. This value is within the healthy range. It has increased from 116.57 (Dec 22) to 133.40, marking an increase of 16.83.
For PBIT / Share (Rs.), as of Dec 23, the value is 119.20. This value is within the healthy range. It has increased from 102.44 (Dec 22) to 119.20, marking an increase of 16.76.
For PBT / Share (Rs.), as of Dec 23, the value is 118.70. This value is within the healthy range. It has increased from 101.56 (Dec 22) to 118.70, marking an increase of 17.14.
For Net Profit / Share (Rs.), as of Dec 23, the value is 90.07. This value is within the healthy range. It has increased from 77.21 (Dec 22) to 90.07, marking an increase of 12.86.
For NP After MI And SOA / Share (Rs.), as of Dec 23, the value is 90.07. This value is within the healthy range. It has increased from 77.21 (Dec 22) to 90.07, marking an increase of 12.86.
For PBDIT Margin (%), as of Dec 23, the value is 31.06. This value is within the healthy range. It has increased from 30.77 (Dec 22) to 31.06, marking an increase of 0.29.
For PBIT Margin (%), as of Dec 23, the value is 27.75. This value exceeds the healthy maximum of 20. It has increased from 27.04 (Dec 22) to 27.75, marking an increase of 0.71.
For PBT Margin (%), as of Dec 23, the value is 27.63. This value is within the healthy range. It has increased from 26.81 (Dec 22) to 27.63, marking an increase of 0.82.
For Net Profit Margin (%), as of Dec 23, the value is 20.97. This value exceeds the healthy maximum of 10. It has increased from 20.38 (Dec 22) to 20.97, marking an increase of 0.59.
For NP After MI And SOA Margin (%), as of Dec 23, the value is 20.97. This value exceeds the healthy maximum of 20. It has increased from 20.38 (Dec 22) to 20.97, marking an increase of 0.59.
For Return on Networth / Equity (%), as of Dec 23, the value is 30.08. This value is within the healthy range. It has decreased from 31.49 (Dec 22) to 30.08, marking a decrease of 1.41.
For Return on Capital Employeed (%), as of Dec 23, the value is 37.75. This value is within the healthy range. It has decreased from 39.67 (Dec 22) to 37.75, marking a decrease of 1.92.
For Return On Assets (%), as of Dec 23, the value is 19.86. This value is within the healthy range. It has decreased from 19.93 (Dec 22) to 19.86, marking a decrease of 0.07.
For Asset Turnover Ratio (%), as of Dec 23, the value is 1.02. It has decreased from 1.04 (Dec 22) to 1.02, marking a decrease of 0.02.
For Current Ratio (X), as of Dec 23, the value is 2.08. This value is within the healthy range. It has increased from 1.87 (Dec 22) to 2.08, marking an increase of 0.21.
For Quick Ratio (X), as of Dec 23, the value is 2.08. This value exceeds the healthy maximum of 2. It has increased from 1.87 (Dec 22) to 2.08, marking an increase of 0.21.
For Dividend Payout Ratio (NP) (%), as of Dec 23, the value is 54.39. This value exceeds the healthy maximum of 50. It has decreased from 60.79 (Dec 22) to 54.39, marking a decrease of 6.40.
For Dividend Payout Ratio (CP) (%), as of Dec 23, the value is 46.98. This value is within the healthy range. It has decreased from 51.39 (Dec 22) to 46.98, marking a decrease of 4.41.
For Earning Retention Ratio (%), as of Dec 23, the value is 45.61. This value is within the healthy range. It has increased from 39.21 (Dec 22) to 45.61, marking an increase of 6.40.
For Cash Earning Retention Ratio (%), as of Dec 23, the value is 53.02. This value is within the healthy range. It has increased from 48.61 (Dec 22) to 53.02, marking an increase of 4.41.
For Interest Coverage Ratio (X), as of Dec 23, the value is 266.43. This value is within the healthy range. It has increased from 133.14 (Dec 22) to 266.43, marking an increase of 133.29.
For Interest Coverage Ratio (Post Tax) (X), as of Dec 23, the value is 180.90. This value is within the healthy range. It has increased from 89.19 (Dec 22) to 180.90, marking an increase of 91.71.
For Enterprise Value (Cr.), as of Dec 23, the value is 31,351.85. It has increased from 22,093.95 (Dec 22) to 31,351.85, marking an increase of 9,257.90.
For EV / Net Operating Revenue (X), as of Dec 23, the value is 9.99. This value exceeds the healthy maximum of 3. It has increased from 7.98 (Dec 22) to 9.99, marking an increase of 2.01.
For EV / EBITDA (X), as of Dec 23, the value is 32.15. This value exceeds the healthy maximum of 15. It has increased from 25.93 (Dec 22) to 32.15, marking an increase of 6.22.
For MarketCap / Net Operating Revenue (X), as of Dec 23, the value is 10.10. This value exceeds the healthy maximum of 3. It has increased from 8.10 (Dec 22) to 10.10, marking an increase of 2.00.
For Retention Ratios (%), as of Dec 23, the value is 45.60. This value is within the healthy range. It has increased from 39.20 (Dec 22) to 45.60, marking an increase of 6.40.
For Price / BV (X), as of Dec 23, the value is 14.49. This value exceeds the healthy maximum of 3. It has increased from 12.51 (Dec 22) to 14.49, marking an increase of 1.98.
For Price / Net Operating Revenue (X), as of Dec 23, the value is 10.10. This value exceeds the healthy maximum of 3. It has increased from 8.10 (Dec 22) to 10.10, marking an increase of 2.00.
For EarningsYield, as of Dec 23, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Dec 22) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of CRISIL Ltd as of April 22, 2025 is: 4,093.37

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 22, 2025, CRISIL Ltd is Overvalued by 12.53% compared to the current share price 4,680.00

Intrinsic Value of CRISIL Ltd as of April 22, 2025 is: 4,660.92

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 22, 2025, CRISIL Ltd is Overvalued by 0.41% compared to the current share price 4,680.00

Last 5 Year EPS CAGR: 13.87%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 45.75%, which is a positive sign. The stock has a low average Working Capital Days of -28.83, which is a positive sign. The company has higher reserves (1,339.25 cr) compared to borrowings (43.17 cr), indicating strong financial stability. The company has shown consistent growth in sales (1.50 cr) and profit (556.92 cr) over the years.	The stock has a high average Cash Conversion Cycle of 58.83, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CRISIL Ltd:
1. Net Profit Margin: 20.97%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 37.75% (Industry Average ROCE: 14.95%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 30.08% (Industry Average ROE: 13.13%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 180.9
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 2.08
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 51.8 (Industry average Stock P/E: 42.17)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Crisil Ltd. is a Public Limited Listed company incorporated on 29/01/1987 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L67120MH1987PLC042363 and registration number is 042363. Currently Company is involved in the business activities of Activities auxiliary to financial service activities. Company's Total Operating Revenue is Rs. 1664.89 Cr. and Equity Capital is Rs. 7.31 Cr. for the Year ended 31/12/2024.

INDUSTRY	ADDRESS	CONTACT
Services - Others	CRISIL House, Central Avenue, Mumbai Maharashtra 400076	investors@crisil.com http://www.crisil.com

Management
Name	Position Held
Mr. Yann Le Pallec	Chairman
Mr. Amish Mehta	Managing Director & CEO
Mr. Girish Paranjpe	Independent Director
Ms. Shyamala Gopinath	Independent Director
Mr. Amar Raj Bindra	Independent Director
Mr. Nishi Vasudeva	Independent Director
Mr. Saugata Saha	Director
Mr. Girish Ganesan	Director

FAQ

What is the intrinsic value of CRISIL Ltd?

CRISIL Ltd's intrinsic value (as of 21 April 2025) is ₹4093.37 — 12.53% lower the current market price of 4,680.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 34,225 Cr. market cap, FY2025-2026 high/low of ₹6,955/3,880, reserves of 2,558 Cr, and liabilities of 3,942 Cr.

What is the Market Cap of CRISIL Ltd?

The Market Cap of CRISIL Ltd is 34,225 Cr..

What is the current Stock Price of CRISIL Ltd as on 21 April 2025?

The current stock price of CRISIL Ltd as on 21 April 2025 is 4,680.

What is the High / Low of CRISIL Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of CRISIL Ltd stocks is ₹6,955/3,880.

What is the Stock P/E of CRISIL Ltd?

The Stock P/E of CRISIL Ltd is 51.8.

What is the Book Value of CRISIL Ltd?

The Book Value of CRISIL Ltd is 351.

What is the Dividend Yield of CRISIL Ltd?

The Dividend Yield of CRISIL Ltd is 1.23 %.

What is the ROCE of CRISIL Ltd?

The ROCE of CRISIL Ltd is 35.6 %.

What is the ROE of CRISIL Ltd?

The ROE of CRISIL Ltd is 27.8 %.

What is the Face Value of CRISIL Ltd?

The Face Value of CRISIL Ltd is 1.00.